Created in 2008, the Oncology Department presently consists of two research units including the Laboratory of Experimental Hemato-Oncology (LHCE) and the Norlux Neuro-Oncology Laboratory (Norlux). Established in 2005, Norlux and LHCE develop their research axis around brain tumours and hematological diseases respectively.
The main activities of the department are focused on experimental cancer research with a strong translational profile and the potential to develop into a clinical outcome. Through a close collaboration with the hospital (Centre Hospitalier du Luxembourg , CHL), the department receives valuable tumour material for research purposes and is involved in clinical studies.
Research activities focus on the cellular and molecular mechanisms of tumor progression using a wide range of state-of-the-art technologies including genomic, transcriptomic and proteomic analyses, as well as in vitro and in vivo imaging modalities (flowcytometry, microscopy, in vivo bioluminescent imaging and magnetic resonance imaging). The department is highly active in the development of novel animal models for cancer research.
The department is also heavily involved in training and teaching activities (Master and PhD student level), as well as in organizing scientific workshops and conferences.
The Oncology Department is headed by Professor Rolf Bjerkvig.